Compass Therapeutics
CMPX
55 hedge funds and large institutions have $401M invested in Compass Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 1 closing their positions.
1,800% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 1
340% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 5
287% more capital invested
Capital invested by funds: $104M → $401M (+$298M)
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
45% more funds holding
Funds holding: 38 → 55 (+17)
3.47% less ownership
Funds ownership: 66.73% → 63.26% (-3.5%)
Top Buyers
| 1 |
Blackstone Inc
New York
|
+$12.4M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$6.21M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$6.21M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.66M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CSS
51
Cubist Systematic Strategies
Stamford,
Connecticut
| $51.8K | +$41.1K | +10,300 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $6K | +$4.63K | +1,160 | New |
|
53
Wells Fargo
San Francisco,
California
| $3.2K | +$714 | +179 | +39% |
|
54
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
55
Bank of America
Charlotte,
North Carolina
| $412 | +$327 | +82 | New |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -675 | Closed |
|
CMPX Hedge Fund Activity: Q4 2022 in Review
55 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q4 2022, worth a combined $401M — up 287% from $104M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CMPX positions and 1 closed out — a net gain of 18 holders — while 22 added to existing stakes and 5 trimmed.
The largest buyer was Blackstone Inc, adding an estimated $12.4M. The largest seller was Janus Henderson Group, cutting an estimated $4.41M.
- 55 institutional investors held Compass Therapeutics (CMPX) as of Q4 2022, up from 38 in Q3 2022.
- Funds reported $401M of Compass Therapeutics stock for Q4 2022, up 287% quarter-over-quarter.
- 19 funds opened new Compass Therapeutics positions in Q4 2022 and 1 closed out, a net change of +18 holders.
- The largest Compass Therapeutics buyer in Q4 2022 was Blackstone Inc, an estimated $12.4M added.
- The largest Compass Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $4.41M sold.
Based on aggregated 13F filings for Q4 2022.